These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 22859217)

  • 1. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
    Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
    Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
    Zhang N; Li J; Luo R; Jiang J; Wang JA
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of bone marrow-derived endothelial progenitor cells attenuates cerebral ischemia and reperfusion injury by inhibiting neuronal apoptosis, oxidative stress and nuclear factor-κB expression.
    Qiu J; Li W; Feng S; Wang M; He Z
    Int J Mol Med; 2013 Jan; 31(1):91-8. PubMed ID: 23151725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
    Yoon YS; Uchida S; Masuo O; Cejna M; Park JS; Gwon HC; Kirchmair R; Bahlman F; Walter D; Curry C; Hanley A; Isner JM; Losordo DW
    Circulation; 2005 Apr; 111(16):2073-85. PubMed ID: 15851615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
    Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
    Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway.
    Liu M; Li Y; Liang B; Li Z; Jiang Z; Chu C; Yang J
    Int J Mol Med; 2018 Apr; 41(4):1867-1876. PubMed ID: 29393353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
    Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
    Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem (iPS) cells inhibit apoptosis and fibrosis in streptozotocin-induced diabetic rats.
    Neel S; Singla DK
    Mol Pharm; 2011 Dec; 8(6):2350-7. PubMed ID: 21988648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.
    Saito S; Teshima Y; Fukui A; Kondo H; Nishio S; Nakagawa M; Saikawa T; Takahashi N
    Cardiovasc Res; 2014 Oct; 104(1):5-14. PubMed ID: 25082849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis.
    Becher PM; Lindner D; Fröhlich M; Savvatis K; Westermann D; Tschöpe C
    Int J Mol Med; 2013 Jul; 32(1):158-64. PubMed ID: 23652584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification.
    Li M; Chen L; Liu X; Wu Y; Chen X; Chen H; Zhong Y; Xu Y
    Biomed Pharmacother; 2024 Aug; 177():117048. PubMed ID: 38959606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of yellow wine polyphenols on cardiomyocyte apoptosis in diabetic cardiomyopathy rats].
    Pan SL; Lin H; Luo HQ; Gao FD; Meng LP; Guo Y; Guo HY; Chi JF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):431-435. PubMed ID: 29926588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
    Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
    Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of bone marrow mesenchymal stem cell transplantation on diabetic cardiomyopathy].
    ZHANG N; LI JH; WANG JA; ZHANG HK
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1115-9. PubMed ID: 19134282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.